Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy (2010)

  • Authors:
  • USP affiliated authors: OLIVEIRA, SORAYA IMON DE - IF ; CHAMMAS, ROGER - FM
  • USP Schools: IF; FM
  • DOI: 10.1186/1471-2407-10-200
  • Subjects: NEOPLASIAS (QUIMIOTERAPIA); ATIVAÇÃO DE PLAQUETAS
  • Language: Inglês
  • Imprenta:
  • Source:
    • Título do periódico: BMC Cancer
    • ISSN: 1471-2407
    • Volume/Número/Paginação/Ano: v. 10, n. 200, p. 1-12, 2010
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1186/1471-2407-10-200 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: gold
    • Licença: cc-by
    Informações sobre o Citescore
  • Título: BMC Cancer

    ISSN: 1471-2407

    Citescore - 2017: 3.49

    SJR - 2017: 1.464

    SNIP - 2017: 1.066


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM1997044-10BCSEP 229 2010
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      OLIVEIRA, Soraya I. de; ANDRADE, Luciana N. S.; ONUCHIC, Ana C.; et al. Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy. BMC Cancer, London, v. 10, n. 200, p. 1-12, 2010. Disponível em: < http://www.biomedcentral.com/content/pdf/1471-2407-10-200.pdf > DOI: 10.1186/1471-2407-10-200.
    • APA

      Oliveira, S. I. de, Andrade, L. N. S., Onuchic, A. C., Nonogaki, S., Fernandes, P. D., Pinheiro, M. C., et al. (2010). Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy. BMC Cancer, 10( 200), 1-12. doi:10.1186/1471-2407-10-200
    • NLM

      Oliveira SI de, Andrade LNS, Onuchic AC, Nonogaki S, Fernandes PD, Pinheiro MC, Rohde CBS, Jancar S, Chammas R. Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy [Internet]. BMC Cancer. 2010 ; 10( 200): 1-12.Available from: http://www.biomedcentral.com/content/pdf/1471-2407-10-200.pdf
    • Vancouver

      Oliveira SI de, Andrade LNS, Onuchic AC, Nonogaki S, Fernandes PD, Pinheiro MC, Rohde CBS, Jancar S, Chammas R. Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy [Internet]. BMC Cancer. 2010 ; 10( 200): 1-12.Available from: http://www.biomedcentral.com/content/pdf/1471-2407-10-200.pdf

    Referências citadas na obra
    Mantovani A, Sica A, Locati M: Macrophage polarization comes of age. Immunity. 2005, 23: 344-6. 10.1016/j.immuni.2005.10.001.
    Gordon S, Taylor PR: Monocyte and macrophage heterogeneity. Nature Reviews. 2005, 5: 953-64.
    Fadok VA, Bratton DL, Konowal A, et al: Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2 and PAF. J Clin Invest. 1998, 101: 890-8. 10.1172/JCI1112.
    Fadok VA, Bratton DL, Henson PM: Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest. 2001, 108: 957-62.
    Oliveira SI, Fernandes PD, Mendes Amarante JG, et al: Phagocytosis of apoptotic and necrotic thymocytes is inhibited by PAF-receptor antagonists and affects LPS-induced COX-2 expression in murine macrophages. Prostaglandins Other Lipid Mediat. 2006, 80: 62-73. 10.1016/j.prostaglandins.2006.04.002.
    Griffiths RJ: Prostaglandins and inflammation. Inflammation: Basic Principles and Clinical Correlates. Edited by: Gallin JI, Snyderman R. 1999, Lippincott & Wilkins, Philadelphia, 249-65.
    Honda Z, Ishii S, Shimizu T: Platelet-activating factor receptor. J Biochem. 2002, 131: 773-9.
    Correa M, Machado J, Carneiro CR, et al: Transient inflammatory response induced by apoptotic cells is an important mediator of melanoma cell engraftment and growth. Int J Cancer. 2005, 114: 356-63. 10.1002/ijc.20673.
    Bussolati B, Biancone LM, Cassoni P, et al: PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. Am J Pathol. 2000, 157: 1713-25.
    Im SY, Ko HM, Kim JW, et al: Augmentation of tumor metastasis by platelet-activating factor. Cancer Res. 1996, 56: 2662-5.
    Fecchio D, Russo M, Sirois P, et al: Inhibition of Ehrlich ascitis tumor in vivo by PAF-antagonists. Int J Immunopharmacol. 1990, 12: 57-65. 10.1016/0192-0561(90)90068-X.
    Fecchio D, Sirois P, Russo M, Jancar S: Studies on the inflammatory response induced by Ehrlich ascitis tumor in mice. Inflammation. 1990, 14: 125-32. 10.1007/BF00914035.
    Wack C, Becker JC, Brocker EB, et al: Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene: results from a murine tumor model. Melanoma Res. 2001, 11: 247-53. 10.1097/00008390-200106000-00006.
    Cruz-Munoz W, Man S, Kerbel RS: Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regimens. Clin Cancer Res. 2009, 15: 4867-74. 10.1158/1078-0432.CCR-08-3275.
    Bartholomew B: A rapid method for the assay of nitrate in urine using the nitrate reductase enzyme of Escherichia coli. Food Chem Toxicol. 1984, 22: 541-3. 10.1016/0278-6915(84)90224-2.
    Coutinho EL, Andrade LN, Chammas R, et al: Anti-tumor effect of endostatin mediated by retroviral gene transfer in mice bearing renal cell carcinoma. FASEB J. 2007, 21: 3153-61. 10.1096/fj.07-8412com.
    Novak EM, Metzger M, Chammas R, et al: Downregulation of TNF-alpha and VEGF expression by Sp1 decoy oligodeoxynucleotides in mouse melanoma tumor. Gene Ther. 2003, 10: 1992-7. 10.1038/sj.gt.3302111.
    Ghosh S, Roy Banerjee SM, et al: Moulation of tumor induced angiogenesis in Ehrlich ascitis tumor. J Exp Clin Cancer Res. 2004, 23: 681-90.
    Zimmerman GA, McIntyre TM, Prescott SM, et al: The Platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med. 2002, 30: S294-S301. 10.1097/00003246-200205001-00020.
    Prescott SM, Zimmerman GA, Stafforini DM, et al: Platelet-activating factor and related lipid mediators. Annu Rev Biochem. 2000, 69: 419-45. 10.1146/annurev.biochem.69.1.419.
    Ko HM, Jung HH, Seo KH, et al: Platelet-activating factor-induced NF-kappaB activation enhances VEGF expression through a decrease in p53 activity. FEBS Lett. 2006, 580: 3006-12. 10.1016/j.febslet.2006.04.042.
    Biancone L, Cantaluppi V, Sorbo Del L, et al: Platelet-activating factor inactivation by local expression of platelet-activating factor acetyl-hydrolase modifies tumor vascularization and growth. Clin Cancer Res. 2003, 9: 4214-20.
    Casals-Stenzel J: Triazolodiazepines are potent antagonists of PAF in vitro and in vivo. Naunyn Schiedeberg's Arch Pharmacol. 1987, 335: 351-5.
    Kim JJ, Tannock IF: Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer. 2005, 5: 516-25. 10.1038/nrc1650.
    Tredan O, Galmarini CM, Patel K, et al: Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst. 2007, 99: 1441-54. 10.1093/jnci/djm135.
    Seo KH, Ko HM, Kim HA, et al: Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation. Cancer Res. 2006, 66: 4681-6. 10.1158/0008-5472.CAN-05-2766.
    Pollard JW: Tumor-educated macrophages promote tumor progression and metastasis. Nat Rev Cancer. 2004, 4: 71-8. 10.1038/nrc1256.
    Karlsson A, Christenson K, Matlak M, et al: Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils. Glycobiology. 2009, 19: 16-20. 10.1093/glycob/cwn104.
    Hsu DK, Chernyavsky AI, Chen HY, et al: Endogenous galectin-3 is localized in membrane lipid rafts and regulates migration of dendritic cells. J Invest Dermatol. 2009, 129: 573-83. 10.1038/jid.2008.276.
    MacKinnon AC, Farnworth SL, Hodkinson PS, et al: Regulation of alternative macrophage activation by galectin-3. J Immunol. 2008, 180: 2650-8.
    Dumont P, Berton A, Nagy N, et al: Expression of galectin-3 in the tumor immune response in colon cancer. Lab Invest. 2008, 88: 896-906. 10.1038/labinvest.2008.54.